Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Preleukemias

P C Nowell

    Human Pathology
    |June 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Preleukemia states, characterized by bone marrow chromosomal abnormalities, indicate an increased risk for leukemia development. These preleukemic disorders share cytogenetic alterations with leukemia, suggesting a common origin from an altered stem cell.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    BCL2 and JUNB abnormalities in primary cutaneous lymphomas.

    The British journal of dermatology·2004
    Same author

    Chronic myelogenous leukemia: laboratory diagnosis and monitoring.

    Genes, chromosomes & cancer·2001
    Same author

    Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation.

    Proceedings of the National Academy of Sciences of the United States of America·2001
    Same author

    Hepatosplenic and subcutaneous panniculitis-like gamma/delta T cell lymphomas are derived from different Vdelta subsets of gamma/delta T lymphocytes.

    The Journal of molecular diagnostics : JMD·2001
    Same author

    t(3;11) translocation in treatment-related acute myeloid leukemia fuses MLL with the GMPS (GUANOSINE 5' MONOPHOSPHATE SYNTHETASE) gene.

    Blood·2000
    Same author

    Panhandle PCR for cDNA: a rapid method for isolation of MLL fusion transcripts involving unknown partner genes.

    Proceedings of the National Academy of Sciences of the United States of America·2000
    Same journal

    TRPS1 and GATA3 Expression in BRG1/SMARCA4-deficient Malignant Neoplasms.

    Human pathology·2026
    Same journal

    Clinicopathologic and Molecular Characteristics of Acral Melanomas Harboring RARA Fusions.

    Human pathology·2026
    Same journal

    Clinical Impact of Second Opinion Consultation in Bladder Biopsies and Transurethral Resection of Bladder Tumors.

    Human pathology·2026
    Same journal

    Prognostic relevance and molecular correlates of Claudin-1 expression in pancreatic neuroendocrine tumors.

    Human pathology·2026
    Same journal

    Mixed Phenotype Acute Leukemia: Lineage Assignment, Immunophenotypic Classification and Genetic Insights.

    Human pathology·2026
    Same journal

    Chronic myelomonocytic leukemia revisited: A comprehensive review with emphasis on the oligomonocytic subtype.

    Human pathology·2026
    See all related articles

    Area of Science:

    • Hematology
    • Cytogenetics
    • Oncology

    Background:

    • A significant number of hemic disorders carry an increased risk for subsequent leukemia development.
    • These preleukemia states encompass various cytopenias, myeloproliferative disorders, and childhood syndromes.

    Purpose of the Study:

    • To investigate the role of chromosomal abnormalities in preleukemia.
    • To determine if cytogenetic alterations in preleukemia share similarities with leukemia.
    • To assess the prognostic value of chromosome studies in preleukemic disorders.

    Main Methods:

    • Analysis of bone marrow chromosomal abnormalities in patients with hemic disorders.
    • Comparison of cytogenetic alterations in preleukemia with those in acute nonlymphocytic leukemia and chronic granulocytic leukemia.

    Related Experiment Videos

    Main Results:

    • Chromosomally abnormal clones are found in a significant number of preleukemia patients.
    • Common cytogenetic alterations include monosomy 7, trisomy 8, 9, 21, 1q+, deletions 5q-, 20q-, and iso 17q.
    • These alterations are similar to those observed in acute nonlymphocytic leukemia and chronic granulocytic leukemia.

    Conclusions:

    • Preleukemic disorders are characterized by a clone of cells derived from an altered hemic stem cell.
    • Preleukemia, chronic leukemia, and acute leukemia may represent a spectrum of disease with varying clone expansion rates.
    • Chromosome studies may offer prognostic value in cytopenic preleukemias, with abnormalities linked to decreased survival and increased leukemia risk.